Home Contact e-mail Site Map l
 
 
 
 
 
RABBITS
Poultry | Rabbits | Swine | Sheep and goats | Cattle | All species

Hipra
Catalogue of products
Diagnostic Kits
Articles and Publications
Veterinarian Resources
Contact
View offersSend us your C.V.
 
   
 
 
Search

In general

LABORATORIOS HIPRA S.A. makes available interesting questions that we belive may be usefull to you:

Cattle
Poultry
Rabbits
Sheep and Goats
Swine

 



Why are there different types of vaccines against Gumboro Disease?
There are three types of vaccines against Gumboro Disease: the mild, intermediate and intermediate plus or “hot” vaccines,  because there are field viruses of different levels of virulence, and different epidemiological situations in which each vaccine would be regarded as the most convenient. To choose the right type of vaccine the following factors should be considered: the pathotype of field virus that you have  on the farm and in the area, the level and quality of protection given by maternal transference and the type of management and biosecurity measures implemented  on the premises.

Related documents
- Molecular characterization of spanish Infectious bursal disease virus field isolates
- Various strategies to successfully control Gumboro disease
- Pathology: Gumboro disease 
-
Related documents


How does one choose between a 1-dose or 2-dose vaccination programme when vaccinating against M. hyopneumoniae?
It is generally expected that a 2-dose vaccination programme would present greater efficacy than one using a single dose. This is because the second dose of vaccine is able to induce a booster effect of animals’ immune systems. Furthermore, 2-dose vaccination programmes are able to overcome more efficaciously the barrier of maternal antibodies coming from colostrum, i.e., they reduce the risk of partial or total neutralisation of the vaccinal antigen. It is recommended that vaccination be delayed in 1-dose programmes so as to avoid partial or total neutralisation of the antigen, thereby reducing the risk of losing vaccinal activity.
It is essential, for each farm, to determine, by using serology and / or PCR, the dynamics of infection by Mycoplasma hyopneumoniae. It can generally be expected that vaccination with two doses is profitable on those farms on which the animals undergo very early infections (during lactation), early ones (during transition) or late ones (in the first few weeks after entering the fattening farm). Nevertheless, vaccination with a single dose will probably be profitable on those farms on which animals undergo very late infections.

Related documents
-
Enzootic pneumonia: the disease
Pathology: Enzootic pneumonia

- Related products


What kinds of vaccines are applied to protect breeding-rabbits against myxomatosis?
The best results have been observed by administering a heterologous vaccine as the primo-vaccination, when one-month-old, and a homologous vaccine, 2 or 2.5 months later. Later semi-annual revaccinations with homologous vaccines protect does throughout their lifetime.
The exclusive administration of heterologous vaccines is recommended when infection pressure is low, while if it is high, homologous vaccines may be used.

Related documents
- Prevention of viral diseases in rabbit keeping
- Comparison of the serological responses from different vaccinal programmes against Myxomatosis and Rabbit haemorrhagic disease
- Rabbit diseases
- Pathology: Myxomatosis
- Vaccinal prophylaxis
- Related documents


Do we obtain a good immune response in calves when they are vaccinated when 1-month old?

The standard recommendation, when vaccinating young calves with a tetravalent virical vaccine (e.g., against BVD, IBR, BRSV, PI-3), is to do the primary vaccination when they are 4 to 6 weeks old and a booster dose 3 or 4 weeks later. The motive for this recommendation is, on the one hand, to prevent the colostral antibodies, which are passively transferred to the calf after birth, from inactivating the vaccinal virus and compromising the response that the immune system must develop after vaccination and revaccination. On the other hand, it is also recommendable for heading off the period of greatest incidence of respiratory processes in young calves that usually increase as of this age.


Two important concepts must be kept in mind; one is the duration of the colostral antibodies and the other is the duration of colostral protection. Colostral antibodies can usually be detected up to 5 or 6 months of age, but the average life of these antibodies is only 4 to 5 weeks. This means the colostral antibodies are reduced by half just one month after birth. This is why vaccination is postponed until this age. It is when protection conferred by the cow has greatly diminished, the risk of infection of the calf and possibility of developing the disease are greater and vaccinal antigens are no longer neutralised and can optimally induce immunity. 


Therefore, vaccination at 4 to 6 weeks and revaccination 3 to 4 weeks later means the vaccinal antigens develop a complete, detectable and serologically measurable immune response.

Related documents
- Bovine pathological processes
- Diagnostic kits



 
 
  Avda. la Selva, 135 -17170 AMER (GIRONA) Spain - Phone: +34 972 43 06 60 - Fax +34 972 43 06 61
Legal warning © 2007 LABORATORIOS HIPRA, S.A. - All rights reserved